Showing results (41-50 of 49) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Innovative Surgical Sciences|June 3, 2024
Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)Miklos Acs, Maximilian Babucke, Maximilian Jusufi, et al.International Journal of Surgery (London, England)|April 25, 2025
Soluble CD46 improves detection of hepatic steatosis by contrast-enhanced computed tomography before liver surgeryPaul Kupke, Laura S Kupke, Gunther Glehr, et al.Nature Medicine|February 1, 2002
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factorMarkus Guba, Philipp von Breitenbuch, Markus Steinbauer, et al.Frontiers in Immunology|February 23, 2018
Predicting Early Viral Control under Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Using Pretreatment Immunological MarkersJames A Hutchinson, Kilian Weigand, Akinbami Adenugba, et al.Transplantation|February 15, 2021
Ribavirin Improves NK Cell IFNγ Response During Sofosbuvir-based DAA Therapy in HCV-infected Liver Transplant RecipientsAkinbami Adenugba, Matthias Hornung, Kilian Weigand, et al.Cancer Immunology, Immunotherapy : CII|August 14, 2023
Immune profile of patients with peritoneal carcinomatosis selected for CRS-HIPEC therapyJulia Kleber, Jordi Yang Zhou, Florian Weber, et al.Anticancer Research|February 2, 2024
Surgical Treatment and Outcome of Ovarian Cancer Patients With Liver Metastases: Experience of a Tertiary Hepatic and Peritoneal Surface Malignancy CenterMiklos Acs, Zoltan Herold, Lea Neumann, et al.Cancers|February 25, 2023
Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor MarkersSebastian Blaj, David Dora, Zoltan Lohinai, et al.Ebiomedicine|June 5, 2024
Soluble CD46 as a diagnostic marker of hepatic steatosisFlorian Bitterer, Paul Kupke, Akinbami Adenugba, et al.Pageof 5